Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,777 | 408 | 66 | N/A | N/A |
| Depreciation Amortization | 19 | N/A | N/A | N/A | N/A |
| Accounts receivable | -831 | N/A | N/A | N/A | N/A |
| Other Working Capital | 3,453 | 5 | 550 | N/A | N/A |
| Other Operating Activity | 46,871 | -1,206 | -1,089 | 0 | 0 |
| Operating Cash Flow | $-2,265 | $-793 | $-473 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -993 | -690 | N/A | N/A |
| PPE Investments | -2 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 41,240 | 1,337 | 0 | 0 |
| Investing Cash Flow | $-2 | $40,247 | $647 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 620 | 1,327 | 690 | N/A | N/A |
| Debt Repayment | N/A | -65 | N/A | N/A | N/A |
| Common Stock Issued | 2,579 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -40,727 | N/A | N/A | N/A |
| Other Financing Activity | 50 | 0 | -8 | 0 | 0 |
| Financing Cash Flow | $3,249 | $-39,465 | $683 | $N/A | $N/A |
| Beginning Cash Position | 877 | 11 | 449 | N/A | N/A |
| End Cash Position | 1,859 | 0 | 11 | N/A | N/A |
| Net Cash Flow | $982 | $-11 | $-438 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,265 | -793 | -473 | N/A | N/A |
| Capital Expenditure | -2 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -2,267 | -793 | -473 | 0 | 0 |